Munafa Stock Market Course + Intraday & FNO calls 
Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Sonoma Pharmaceuticals (SNOA)
Technical Analysis Report for USA stock SNOA Sonoma Pharmaceuticals. Dated: 22 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals then click here. or read Experts views on Sonoma Pharmaceuticals or Forecast & share price targets of Sonoma Pharmaceuticals
Sonoma Pharmaceuticals Opened at 1.16 and Closed at: 1.11, which is 4.5% of previous session's close. It moved within a range of 1.06 and 1.16
The session was a Bearish session with an average volume of 98717, which is -67.55% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 1.04 and resistance for tomorrow is 1.14
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.06, 1.01 resistance for tomorrow's hourly charts is 1.16, 1.21
10 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.1 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.13 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.78 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.45 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Sonoma Pharmaceuticals is 3.2 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Sonoma Pharmaceuticals is at 1.13 and 200 DMA is at 3.2, while 50 DMA and 100 DMA are at 1.78 and 2.45 respectively
Sonoma Pharmaceuticals (SNOA) moving average of 20 SMA is at 1.13 and 20 EMA is at 1.24
| Date | Closing Price | 20 SMA | 20 EMA |
| 22 Fri May | 1.11 | 1.13 | 1.24 |
| 21 Thu May | 1.06 | 1.13 | 1.25 |
| 20 Wed May | 1.07 | 1.14 | 1.27 |
| 19 Tue May | 1.01 | 1.17 | 1.29 |
| 18 Mon May | 1.03 | 1.22 | 1.32 |
| 15 Fri May | 1.09 | 1.28 | 1.35 |
Sonoma Pharmaceuticals (SNOA) moving average of 50 SMA is at 1.78 and 50 EMA is at 1.72
| Date | Closing Price | 50 SMA | 50 EMA |
| 22 Fri May | 1.11 | 1.78 | 1.72 |
| 21 Thu May | 1.06 | 1.81 | 1.74 |
| 20 Wed May | 1.07 | 1.83 | 1.77 |
| 19 Tue May | 1.01 | 1.86 | 1.8 |
| 18 Mon May | 1.03 | 1.89 | 1.83 |
| 15 Fri May | 1.09 | 1.92 | 1.86 |
Sonoma Pharmaceuticals (SNOA) moving average of 100 SMA is at 2.45 and 100 EMA is at 2.23
| Date | Closing Price | 100 SMA | 100 EMA |
| 22 Fri May | 1.11 | 2.45 | 2.23 |
| 21 Thu May | 1.06 | 2.47 | 2.25 |
| 20 Wed May | 1.07 | 2.5 | 2.27 |
| 19 Tue May | 1.01 | 2.52 | 2.29 |
| 18 Mon May | 1.03 | 2.55 | 2.32 |
| 15 Fri May | 1.09 | 2.57 | 2.35 |
Sonoma Pharmaceuticals (SNOA) moving average of 200 SMA is at 3.2 and 200 EMA is at 2.59
| Date | Closing Price | 200 SMA | 200 EMA |
| 22 Fri May | 1.11 | 3.2 | 2.59 |
| 21 Thu May | 1.06 | 3.21 | 2.6 |
| 20 Wed May | 1.07 | 3.22 | 2.62 |
| 19 Tue May | 1.01 | 3.23 | 2.64 |
| 18 Mon May | 1.03 | 3.24 | 2.66 |
| 15 Fri May | 1.09 | 3.25 | 2.68 |
Sonoma Pharmaceuticals has performed better than Teleflex Incorporated in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Merck Company has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Merck Company, about 4.52% more returns!
Sonoma Pharmaceuticals has performed better than Molina Healthcare in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Vistagen Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Vistagen Therapeutics, about 1.6% more returns!
Sonoma Pharmaceuticals has performed better than Viking Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Twist Bioscience in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Tiziana Life has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Tiziana Life, about 12.47% more returns!
Sonoma Pharmaceuticals has performed better than Natera Inc in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Neogen Corporation in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Kalvista Pharmaceuticals has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 32.51% more returns!
Galectin Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 1.03% more returns!
Sonoma Pharmaceuticals has performed better than Fonar Corporation in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Cerus Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Cerus Corporation, about 30.83% more returns!
Sonoma Pharmaceuticals has performed better than Accuray Incorporated in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Ani Pharmaceuticals in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Akebia Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals Technical analysis of indicators
Price action analysis of Sonoma Pharmaceuticals (SNOA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Sonoma Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Sonoma Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Sonoma Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.08 and Sonoma Pharmaceuticals SNOA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Sonoma Pharmaceuticals SNOA stock. Volume based technical analysis of Sonoma Pharmaceuticals SNOA stock is negative.
Sonoma Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SNOA Experts View which covers a lot of information including buying and selling signals
SNOA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sonoma Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
